Average Co-Inventor Count = 3.90
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Rhizen Pharmaceuticals Sa (15 from 51 patents)
2. Incozen Therapeutics Pvt. Ltd. (2 from 7 patents)
15 patents:
1. 10442783 - 2,3-disubstituted chromen-4-one compounds as modulators of protein kinases
2. 10174034 - Modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancer
3. 10072013 - Selective PI3K delta inhibitors
4. 9775841 - Compounds as modulators of protein kinases
5. 9669033 - Selective PI3K delta inhibitors
6. 9475818 - Selective PI3K delta inhibitors
7. 9181214 - Bicyclic compounds as modulators of GPR-119
8. 9150579 - Selective PI3K delta inhibitors
9. 9018375 - Substituted chromenes as kinase modulators
10. 8993612 - Modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancer
11. 8921364 - Modulators of calcium release-activated calcium channel
12. 8912331 - 3,5-disubstituted-3H-imidazo[4,5-B]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of protein kinases
13. 8686048 - Immunomodulator and anti-inflammatory compounds
14. 8481739 - 3,5-Disubstituted-3H-imidazo[4,5-b]pyridine and 3,5-disubstituted-3H[1,2,3]triazolo [4,5-b] Pyridine Compounds as Modulators of protein kinases
15. 8377970 - Modulators of calcium release-activated calcium channel